Chunmei Ji, PhD
Vice President, Head of Toxicology
Chunmei Ji joined BridgeBio Pharma in October 2023 and is now Vice President, Head of Toxicology for BBOT. She brings more than 20 years of experience in the pharmaceutical industry, focusing on drug development and overseeing nonclinical safety programs from initial IND submission to marketing registration. Before joining BridgeBio, Chunmei served as a Nonclinical Safety Lead, collaborating on the design of integrated development strategies to support global development for novel therapies in the oncology, immunology, neurology, and pain management therapeutic areas. She has considerable experience in nonclinical safety assessment, supporting complex clinical programs and regulatory marketing applications for global organizations, including Nektar Therapeutics, Novartis, and Johnson & Johnson.
Chunmei is a DABT-certified toxicologist and received her PhD in Pharmacology and Toxicology from UC Davis, and an MD from Fudan University.